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1 These two authors equally contributed to this worLoss of ALS2/alsin function accounts for several recessive motor neuron diseases. ALS2 is a Rab5 acti-
vator and its endosomal localization is regulated by Rac1 via macropinocytosis. Here, we show that
the pathogenic missense ALS2 mutants fail to be localized to Rac1-induced macropinosomes as well
as endosomes, which leads to loss of the ALS2 function as a Rab5 activator on endosomes. Further,
these mutants lose the competence to enhance the formation of amphisomes, the hybrid-organelle
formed upon fusion between autophagosomes and endosomes. Thus, Rac1-induced relocalization of
ALS2 might be crucial to exert the ALS2 function associated with the autophagy-endolysosomal deg-
radative pathway.
Structured summary:
Rac1 physically interacts with ALS2 by pull down (View interaction)
Rab5A physically interacts with ALS2 by pull down (View Interaction 1, 2)
ALS2 and EEA1 colocalize by ﬂuorescence microscopy (View Interaction 1, 2, 3)
ALS2 physically interacts with ALS2 by anti tag coimmunoprecipitation (View interaction)
 2011 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
Mutations in the ALS2 gene account for several recessive motor
neuron diseases (MNDs), including amyotrophic lateral sclerosis 2
[1], demonstrating that the ALS2 protein (ALS2 or alsin) is essential
for motor neurons. ALS2 contains three predicted guanine nucleo-
tide exchange factor (GEF) domains [2,3], i.e., the regulator of
chromosome condensation 1 (RCC1)-like domain (RLD), the
Dbl-homology and pleckstrin-homology (DH/PH) domain, and the
vacuolar protein sorting 9 (VPS9) domain [2,3]. In addition, eight
consecutive membrane occupation and recognition nexus (MORN)chemical Societies. Published by E
is; GEF, guanine nucleotide
ensation 1-like domain; DH,
lar protein sorting 9; MORN,
lecular Life Sciences, Tokai
9-1193, Japan. Fax: +81 463
no).
k.motifs are noted in the region between the DH/PH and VPS9
domains.
We and others have reported that ALS2 acts as a GEF for Rab5
(Rab5GEF) [4–6]. Rab5 is a key regulator in endocytosis, endosome
fusion, and endosome trafﬁcking [7]. Indeed, it has been shown
that ALS2 regulates endosome fusion and trafﬁcking by activating
Rab5 [4,5]. Further, we have demonstrated that ALS2 is a novel
Rac1 effector [8] rather than a Rac1GEF [5], and plays a role in
macropinocytosis and the following endosome maturation [8].
Activated Rac1 interacts with ALS2 and induces the relocalization
of ALS2 from cytoplasm to membranous compartments (e.g., mem-
brane rufﬂe, macropinosome, and endosome) [8]. This Rac1-
mediated relocalization of ALS2 is required for the ALS2-mediated
Rab5 activation on the membranous compartments.
As almost all mutations identiﬁed in the ALS2 gene result in the
truncation of the C-terminal Rab5GEF domain of ALS2, loss of the
ALS2-associated Rab5GEF activity may underlie the pathogenesis
of ALS2-linked MNDs [1]. Recently, two missense mutations in
the ALS2 gene were identiﬁed [9,10]. Both mutations result in the
mutant proteins (ALS2C157Y and ALS2G540E) carrying a singlelsevier B.V. All rights reserved.
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A. Otomo et al. / FEBS Letters 585 (2011) 730–736 731amino-acid substitution in the N-terminal RLD of ALS2 (ALS2-RLD)
with a preservation of the C-terminal Rab5GEF domain [9,10].
These missense mutations might lead to loss of the ALS2 function,
because the pedigrees carrying these mutations are consistent
with an autosomal recessive inheritance [9,10]. However, the
molecular mechanism by which the missense mutations cause loss
of the ALS2 function is still unknown. To directly address this issue,
we here investigated the molecular and cellular functions of these
two pathogenic mutants.0
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Fig. 2. In vitro Rab5GEF activity of the ALS2 mutants. GDP-loaded recombinant
Rab5A were incubated with a variety of puriﬁed proteins (control; without proteins,
FLAG-ALS2WT, FLAG-ALS2C157Y, FLAG-ALS2G540E, and FLAG-ALS2_RLD) for 1 h.
Percentage of dissociated GDP is shown. Values are means ± SD (each sample;
n = 5–6). There are signiﬁcant differences in the GDP dissociation activity between
control and indicated samples (⁄⁄⁄P < 0.001).2. Materials and methods
2.1. Quantiﬁcation of cellular phenotypes
HeLa cells were cotransfectedwith pCMV10-2XHA-Rac1Q61L and
either pCIneo-FLAG-ALS2WT, -ALS2C157Y, -ALS2G540E, -ALS2T510A,
or -ALS2P1603A as previously described [8]. Twenty-four hours after
transfection, the cells were ﬁxed, permeabilized, and co-stained
with anti-ALS2 (HPF1-680) and anti-Rac1 antibodies (Abs). Two
hundred cells expressing FLAG-tagged ALS2 with HA-tagged
Rac1Q61L were examined. The phenotypes of the cells were catego-
rized into two groups; i.e., ‘cytoplasmic’ and ‘macropinosome (at
least four vesicles/cell were over 2 lm in diameter)’, based on the
localization of ALS2. Each value represents the mean and standard
deviation of at least ﬁve independent experiments. Statistical signif-
icance was evaluated by ANOVA with Bonferroni’s post hoc test.RLD
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Fig. 1. (A) Schematic diagram of ALS2 and its mutants. The pathogenic mutations identiﬁed in the RLD are indicated by arrowheads, and the other mutations are indicated by
arrows. It has been shown that Threonine-510 is phosphorylated [12]. Proline-1603 is a crucial amino acid residue to the GEF activity on Rab5 [4]. (B) ALS2 interacts with Rac1
and Rab5. Recombinant GST and GST-fused proteins were mixed with lysates from the cells expressing FLAG-ALS2 or its mutants, and pulled down by glutathione-conjugated
beads. Pulled down samples were immunoblotted and probed with anti-FLAG M2 Ab. Amounts of GST-fusion proteins used in these experiments are shown by CBB staining.
A10
ALS2C157Y+Rac1Q61L ALS2G540E+Rac1Q61L ALS2WT +Rac1Q61L
ALS2T510A+Rac1Q61L ALS2P1603A+Rac1Q61L Rac1Q61L
D
B,C B. Macropinosomes C. Early endosomes
R
ac
1Q
61
L 
Dextran ALS2 Merge EEA1 ALS2 Merge
Mock
ALS2WT
ALS2C157Y
ALS2G540E
ALS2T510A
ALS2P1603A
Rac1Q61L -induced ALS2 macropinosomal localization 
1. ALS2WT
2. ALS2C157Y
3. ALS2G540E
4. ALS2T510A
50
40
30
20
10
0
1 2 3 4
*** ***
(%)
N.S.
Fig. 3. Pathogenic ALS2 mutants fail to be localized to Rac1-induced macropinosomes and endosomes. (A) Confocal microscopic images represent the localization of FLAG-
ALS2WT, FLAG-ALS2C157Y, FLAG-ALS2G540E, FLAG-ALS2T510A, and FLAG-ALS2P1603A in 2XHA-Rac1Q61L expressing cells. Both white and yellow arrowheads indicate Rac1Q61L-
induced macropinosomes. The insets represent the typical Rac1-induced macropinosomes (corresponding to yellow arrowheads) with a higher magniﬁcation. (B and C) FLAG-
ALS2WT, FLAG-ALS2T510A, and FLAG-ALS2P1603A, but not pathogenic mutants FLAG-ALS2C157Y and FLAG-ALS2G540E, are localized to Rac1-induced dextran-positive nascent
macropinosomes (B, arrows) and macropinosome-derived EEA1-positive endosomes (C, arrows). (D) Quantiﬁcation of Rac1-mediated macropinosomal localization of ALS2.
The values are shown as mean ± S.D. (each genotype; n = 6–7). There are signiﬁcant differences in the percentage of the cells showing macropinosomal localization of ALS2
between indicated genotypes (⁄⁄⁄P < 0.001). Scale bars shown in (A) in the main and inset images indicate 10 and 2 lm, respectively. Scale bars shown in (B) and (C) indicate
5 lm.
732 A. Otomo et al. / FEBS Letters 585 (2011) 730–736
LPA  1
LPC  2
PI  3
PI(3)P  4
PI(4)P  5
PI(5)P  6
PE  7
PC  8
9    S1P
10  PI(3.4)P 2
11  PI(3.5)P 2
12  PI(4.5)P 2
13  PI(3.4.5)P3
14  PA
15  PS
16  B
FLAG ALS2WT ALS2C157Y ALS2G540E
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
BA
Fig. 4. ALS2C157Y and ALS2G540E show lower afﬁnities to PI(3)P and PI(4)P. (A) Layout of strips is as follows. Spot 1: Lysophosphatidic acid (LPA); 2: Lysophosphatidylcholine
(LPC); 3: Phosphatidylinositol (PI); 4: PI(3)P; 5: PI(4)P; 6: PI(5)P; 7: Phosphatidylethanolamine (PE); 8: Phosphatidylcholine (PC); 9: Sphingosine 1-phosphate (SP1); 10:
PI(3,4)P2; 11: PI(3,5)P2; 12: PI(4,5)P2; 13: PI(3,4,5)P3;14: Phosphatidic acid (PA); 15: Phosphatidylserine (PS); 16: Blank. (B) Both ALS2C157Y and ALS2G540E show lower
afﬁnities to PI(3)P and PI(4)P. Association between ALS2 and PIPs was analyzed by protein-lipid overlay assay. PIP strips™ was incubated with puriﬁed FLAG-peptide, FLAG-
ALS2WT, or the mutants, followed by probing with anti-ALS2 Ab.
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including antibodies, plasmid constructs, Western blot analysis
and gel staining, cell culture and transfection, in vitro GST pull
down assay, co-immunoprecipitation, in vitro GEF assay, immuno-
cytochemistry, confocal microscopy, dextran-uptake assay, and
protein-lipid overlay assay are available in the Supplementary data.
3. Results
3.1. Pathogenic ALS2 mutants interact with Rac1 and Rab5
ALS2 interacts with both Rac1 and Rab5 [4,5,8]. Thus, we ﬁrst
analyzed whether the pathogenic mutants (Fig. 1A) interacted with
Rac1 and Rab5. Consistent with the previous report [8], FLAG-
ALS2WT was pulled down with GST-Rac1 and GST-Rab5, but not
with GST, GST-Cdc42, and GST-RhoA (Fig. 1B). Notably, both mu-
tants were also efﬁciently pulled down with either GST-Rac1 or
GST-Rab5 but not with GST, GST-Cdc42, and GST-RhoA (Fig. 1B),
as was ALS2WT.
3.2. Pathogenic ALS2 mutants retain the Rab5GEF activity
Next, we analyzed the Rab5GEF activities of the pathogenic mu-
tants by in vitro GDP dissociation assay. Both mutants stimulated
the GDP dissociation from Rab5A, although they showed slightly
lower activities than ALS2WT (Fig. 2A). Consistently, neither patho-
genic missense mutations abolished the ALS2 self-association com-
petence (Supplementary Fig. 1) [6]. These results indicate that the
pathogenic ALS2 mutants retain the ability to activate Rab5
in vitro.
3.3. Missense mutations in the ALS2-RLD result in mislocalization of
ALS2
Rac1-induced relocalization of ALS2 is necessary to proceed
with the ALS2-mediated activation of Rab5 on membranous com-
partments. Thus, we assume that the mutants fail to be relocalized
to membranous compartments irrespective of their Rac1 binding
properties, which results in loss of the ALS2 function as a Rab5GEF
on membranous compartments. To verify this, we examined
whether the Rac1-dependent subcellular relocalization of the mu-
tants were affected. We expressed ALS2WT or its mutant proteins
with constitutively activated-Rac1 mutant (Rac1Q61L) in HeLa cells,
and observed the localization of ALS2 in Rac1Q61L expressing cells.
Expression of Rac1Q61L induced macropinosomes (large phase
bright organelle, over 2 lm in diameter, indicated by arrowheads
in Fig. 3A) arisen from peripheral and/or dorsal membrane rufﬂes
as previously reported [11].Although ALS2WT was widely distributed throughout the cyto-
plasm (Supplementary Fig. 2), it was redistributed to membrane
rufﬂes and dextran-positive nascent macropinosomes in a Rac1Q61L
dependent manner (Fig. 3A and B). Further, a signiﬁcant proportion
of ALS2 was colocalized with EEA1 (endosome marker) (Fig. 3C),
suggesting that ALS2-localizing macropinosomes matured into
early endosomes (EEs). Interestingly, unlike ALS2WT, both
ALS2C157Y and ALS2G540E failed to be localized to both Rac1Q61L-in-
duced macropinosomes and macropinosome-derived EEs, and yet
sequestered in the cytoplasm (Fig. 3A–C). Quantitative analysis re-
vealed that ALS2WT was localized to macropinosomes in over 40%
of the Rac1Q61L/ALS2WT-expreeessing cells, whereas both ALS2C157Y
and ALS2G540E were almost devoid of macropinosomal localization
[ALS2WT, 42.00 ± 4.76%; ALS2C175Y, 0.28 ± 0.48%; ALS2G540E,
0.50 ± 0.54%] despite that a comparable number of macropino-
somes was observed (Fig. 3A and B). Conversely, both mutants
were widely distributed throughout the cytoplasmwithout localiz-
ing to small endosomes and membrane rufﬂes in over 80% of the
cells expressing Rac1Q61L (Supplementary Fig. 3). By contrast, the
ALS2 mutants carrying a single amino-acid substitution on a phos-
phorylation site [12] of the ALS2-RLD (ALS2T510A) or a critical site
for Rab5GEF activity in the VPS9 domain (ALS2P1603A) [4] were
localized to Rac1Q61L-induced macropinosomes and EEs
(Fig. 3A–C), as was ALS2WT, although expression of ALS2P1603A
slightly inhibited EEA1 recruitment [8]. These results suggest that
the seemingly non-pathogenic amino-acid substitution in the RLD
may not disturb the Rac1Q61L-dependent macropinosomal localiza-
tion of ALS2. Collectively, our data demonstrate that the disease
causing missense mutations in the ALS2-RLD speciﬁcally result in
the mislocalization of ALS2 in cell.
3.4. Pathogenic ALS2 mutants show a lower afﬁnity to
phosphatidylinositol phosphates
To clarify the mechanisms of mislocalization of the ALS2 mu-
tants, we tested whether the ALS2 mutants could associate with
phosphoinositide phosphates (PIPs). Since ALS2 has putative lipid
association domains and motifs; i.e., RLD [8], DH/PH [2,3] and
MORN [2,3] (Fig. 1A), we assume that macropinosomal localization
of ALS2 is regulated by the lipid association. We performed PIP-
Strip overlay assay using puriﬁed FLAG-ALS2WT and the mutants.
FLAG-ALS2WT showed strong afﬁnities to several PIPs including
phosphatidylinositol-3-phosphate [PI(3)P], phosphatidylinositol-
4-phosphate [PI(4)P], phosphatidylinositol-5-phosphate [PI(5)P],
and phosphatidylinositol-3,5-phosphate [PI(3,5)P2] (Fig. 4). Nota-
bly, both FLAG-ALS2C157Y and FLAG-ALS2G540E exhibited lower
afﬁnities to PI(3)P and PI(4)P compared to FLAG-ALS2WT (Fig. 4).
These results, combined with a recent ﬁnding indicating that
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maturation and traffﬁcking after macropinocytosis [13], suggest
that binding to speciﬁc PIPs, particularly PI(3)P, might regulate
macropinosomal localization of ALS2, and that loss of such associ-
ation in pathogenic ALS2 mutants may explain the preferential
cytosolic distribution of these proteins.3.5. Pathogenic ALS2 mutants do not act as an activator for Rab5 in
cells
We next clariﬁed the effect of ALS2 mislocalization in cells. To
investigate whether the mislocalization of ALS2 causes a change
in the activity of ALS2-mediated early endosomes (EEs) fusion
A. Otomo et al. / FEBS Letters 585 (2011) 730–736 735[4], we expressed ALS2WT or the mutants in HeLa cells, and ana-
lyzed the morphology of EEA1-positive EEs. Consistent with the
previous reports [4], expression of ALS2WT induced EEs enlarge-
ment (Fig. 5A, white arrowheads). Remarkably, both ALS2C157Y
and ALS2G540E expression failed to induce EEs enlargement, as
did the Rab5-GEF activity deﬁcient mutant (ALS2P1603A) (Fig. 5A).
These results indicate that mislocalization of ALS2 leads to loss of
ALS2 competence to act as an activator for Rab5 in cells.
3.6. Pathogenic ALS2 mutants lose the competence to enhance the
amphisome formation
Finally, we examined whether expression of ALS2 or its mutants
regulate the autophagy-endolysosomal system. Recently, we have
reported that ALS2 deﬁciency causes the delay of autophago-
endolysosome mediated protein degradation [14]. Since a
subpopulation of autophagosomes are fused with EEs and form hy-
brid-organelle called amphisomes before they fuse with lysosomes
[15], we hypothesize that ALS2 plays a role in the autophagy-endo-
lysosomal pathway by regulating the formation of amphisomes
through its Rab5 GEF activity. To verify this, we examined the colo-
calization of EEA1 (endosome marker) and microtubule-associated
protein 1A/1B-light chain 3 (LC3) (autophagosome marker) in
vesicular compartments. Expression of ALS2WT induced enlarged
EEA1-positive vesicles that were colocalized with LC3 (Fig. 5B,
white arrowheads), indicating an enhanced formation of amphi-
somes. By contrast, expression of ALS2P1603A did not induce en-
larged amphisomes (Fig. 5B). Notably, expression of neither
ALS2C157Y nor ALS2G540E enhanced the formation and/or enlarge-
ment of amphisomes (Fig. 5B). These results indicate that like
Rab5-GEF activity-defective ALS2, relocalization-defective ALS2
mutants lead to the decreased formation of amphisomes in cells.
4. Discussion
In this study, we demonstrated that the pathogenic missense
mutations in the ALS2-RLD impaired Rac1-induced relocalization
of ALS2, probably by decreasing the afﬁnities to speciﬁc lipid mol-
ecules in membranes. Further, these mutants lost the competence
to enhance the formation of amphisomes in cells. Based on these
ﬁndings, mislocalization of ALS2 leads to loss of the ALS2 function
as a Rab5 activator on macropinosomes/endosomes, resulting dis-
turbance of the autophagosome and endosome maturation, might
account for the ALS2-linked MNDs.
Previously, we have shown that loss of the ALS2-associated
Rab5GEF activity underlies the pathogenesis of ALS2-linked MNDs
[1,4]. Further, the ALS2-associated Rab5GEF activity is involved in
macropinocytosis and the following early endocytic pathway
[4,5,8]. Although the physiological role of macropinocytosis is still
unclear, macropinocytosis may link cargo molecules for the incor-
poration into macropinosomes to the degradative pathway [16].
Since ALS2 activates Rab5 on macropinosomes and endosomes, it
may enhance endosome trafﬁcking leading to the degradation of
certain cargo molecules that are endocytosed via macropinocyto-
sis. Indeed, we have shown that mouse embryonic ﬁbroblasts
derived from Als2-knockout mice displays slower degradation rate
of endocytosed epidermal growth factor [17]. Further, loss of ALS2
in a mutant Cu/Zn-superoxide dismutase (SOD1H46R)-expressing
ALS mouse model results in the delay of autophago-lysosome
mediated protein degradation and accelerates neurodegeneration
[14]. Moreover, we here demonstrated that ALS2-mediated Rab5
activation was involved in the amphisome formation, which may
link the endocytosed molecules to autophago-lysosome mediated
protein degradation. Collectively, ALS2 is implicated in macropino-
cytosis, endosome trafﬁcking, and the following degradativepathways. Thus, loss of ALS2 might promote the accumulation of
misfolded proteins in particular groups of motor neurons and
neurodegeneration.
Future studies on the molecular basis of ALS2 may uncover the
roles for macropinocytosis in selective cargo sorting and degrada-
tion, which bring new insights into the molecular pathogenesis for
ALS2-linked MNDs and other neurodegenerative diseases.Acknowledgements
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